Patrícia A. Serra finished her PhD at the Research Institute for Medicines (iMed.ULisboa) working on the discovery of multiple new hit compounds that can be used as useful starting points to initiate hit-to-lead programs towards drug candidates for HIV-1 and HIV-2 therapy, using computational techniques. She graduated in Pharmacy specialized in Pharmaceutical and Therapeutic Chemistry in 2021 from the Universidade de Lisboa Faculdade de Farmácia. She holds a bachelor degree in Chemistry and a master degree in Chemistry specialising in Chemistry, Health and Nutrition from the University of Lisboa Faculty of Sciences, with main experience in organic synthesis. Patrícia A. Serra is a Post-doc researcher at Champalimaund Foundation at the Universidade de Lisboa Faculdade de Farmácia working toward an enhanced efficacy of platinum-based therapy in non-small cell lung cancer using novel inhibitors of Nucleotide Excision Repair. My mission relies on the use of computational techniques to identify a set of new molecular identities of potential NER inhibitors that target specific structures in the mechanism. Published 6 articles in scientific journals, 2 as the first author, and participated in several events, with 7 oral communications and 31 poster communications.